IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome

计划入组 68 人 · 首次发布于 2018 年 4 月 19 日

Phase I Trial of IDH1 Peptide Vaccine in IDH1R132H-mutated Grade III-IV Gliomas

计划入组 39 人 · 首次发布于 2015 年 5 月 27 日

CDH1-associated Blepharocheilodontic Syndrome Registry

计划入组 100 人 · 首次发布于 2025 年 8 月 21 日

bH1

BLH1-13I

VGH-BPH1

Ketone Body β-Hydroxybutyrate Enhances CAR T Cell Therapy Efficacy in Preclinical Studies, Human Trials Underway

Real-World Data Confirm Ivosidenib Efficacy in IDH1-Mutated Cholangiocarcinoma

Olutasidenib Plus Azacitidine Shows Promise in IDH1-Mutated Relapsed/Refractory AML